AbelsonTaylor
Independent
Address
433 W. Van Buren St.
Chicago, Illinois 60602
Web Address
Year Founded
1981
Full-time Employees
284
North American Revenue 2022
Full-time Employees 2022
Number of clients 2022
Offices
North America
1
Locations
Chicago, IL
Executives & Senior Management
Dale Taylor
CEO
Jeff Berg
President
Jay Carter
EVP, Director of Business Development
Senior Management
Dale Taylor
CEO
Agency 100 T-Shirt
Capabilities/Services Offered
Professional
Consumer
OTC
Direct Marketing
Media Planning
Med-Tech
Data/Analytics
Digital
New Services
AT initiated a broad development plan to significantly increase our marketing intelligence integration into our clients marketing plans. We have designed and implemented a streamlined data aggregation platform that enables multitouch attribution modeling and performance benchmarking for our clients across both NPP and sales. As part of our MI development, we have also deployed rapid experimentation, audience personalization and dynamic content optimization in our clients digital marketing mix; all dramatically increasing the ability of our clients to meet there goals at a greater efficiencies.
New Roles
Roles Added
10
Roles
Lisa Brigham - Director of Talent Acquisition
Client Roster
Aerovate Therapeutics AV-101
Arcutis Biotherapeutics ARQ-154
Arcutis Biotherapeutics Zoryve
Astellas Pharma AmBisome
Astellas Pharma Anti-Infective Franchise
Astellas Pharma Cresemba
Avanos Coolief
Biogen-Sage Zuranolone
City of Hope City of Hope Comprehensive Cancer Center
Coherus Cimerli
Coherus Udenyca
Cooper Medical Fertility
CooperSurgical ALLY
CooperSurgical EndoSee
CooperSurgical Insorb
CooperSurgical Mara
CSL Behring Acquired Bleeding Global
CSL Behring Afstyla Global
CSL Behring Afstyla US
CSL Behring CSL312
CSL Behring Haegarda
CSL Behring Haemate-P US
CSL Behring HEMGENIX
CSL Behring Hizentra CIDP Global
CSL Behring Hizentra CIDP US
CSL Behring Hizentra PI US
CSL Behring Idelvion Global
CSL Behring Idelvion US
CSL Behring Kcentra
CSL Behring Privigen Global
CSL Behring Privigen PI/ITP
CSL Behring VWD Global
Fresenius Kabi Idacio Global
Fresenius Kabi Idacio US
Fresenius Kabi Toci Global
Fresenius Kabi Toci US
G1 Therapeutics Cosela
Karyopharm Therapeutics Xpovio
Neurocrine Biosciences Ingrezza DTC/HCP
Neurocrine Biosciences Ingrezza HD
Pharmacosmos Monoferric
PharmaEssentia BESREMi
Sage Therapeutics 718
Seres Therapeutics/Aimmune Therapeutics SER-109
Takeda Pharmaceuticals Motegrity
Vericel Maci
Vericel Nexobrid
Growth
2022 Growth from Existing Clients
25%
2022 Growth from New Clients
15%
Trends and Challenges
Diversity and inclusion
Talent acquisition/retention
Managing growth
Payer-related challenges
Pricing-related issues
Getting an audience, virtually or otherwise, with HCPs
Keeping up with pace of innovation
Procurement-related issues
Shrinking pharma budgets
Further diversification of services
Pandemic-related disruptions
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
More digital experimentation
Working from home
Ongoing fallout from pandemic
Creative Samples
